arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Bone Biologics Corp

BBLG

$0.35 ▼ -0.02 (-5.34%) at close

19 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Bone Biologics Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -47.5% ↗

FCF / Share $-2.29 ↗

Trailing P/E —

Price / Book 0.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 4, 2026.

19-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.07B

— 0.0% —

Net Income Profit after all expenses

$-3.11M

↑ +24.4% —

Operating Margin Operating profit as % of sales

-0.1%

↑ +66.3% —

FCF / Share Free cash flow per share

$-2.29

↑ +86.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗	FY 2010 Oct 31, 2010 10-K ↗	FY 2009 Oct 31, 2009 10-K ↗	FY 2008 Oct 31, 2008 10-K ↗	FY 2007 Oct 31, 2007 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	90.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	14.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-9.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	24.4% Good ↑ Good Improving Year-over-year change in net income	54.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-502.8% Weak ↓ Weak Declining Year-over-year change in net income	7.8% Fair ↓ Fair Declining Year-over-year change in net income	11.7% Fair ↓ Fair Declining Year-over-year change in net income	46.7% Excellent ↑ Excellent Improving Year-over-year change in net income	22.7% Good ↑ Good Improving Year-over-year change in net income	37.2% Excellent ↑ Excellent Improving Year-over-year change in net income	72.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-86.5% Weak ↑ Weak Improving Year-over-year change in net income	-213.6% Weak ↑ Weak Improving Year-over-year change in net income	-308.8% Weak ↑ Weak Improving Year-over-year change in net income	-1715.8% Weak ↓ Weak Declining Year-over-year change in net income	-1111.4% Weak ↓ Weak Declining Year-over-year change in net income	-36.8% Weak ↓ Weak Declining Year-over-year change in net income	65.0% Excellent Excellent Year-over-year change in net income	22.9% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	86.0% Excellent Excellent Year-over-year change in free cash flow	55.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗	FY 2010 Oct 31, 2010 10-K ↗	FY 2009 Oct 31, 2009 10-K ↗	FY 2008 Oct 31, 2008 10-K ↗	FY 2007 Oct 31, 2007 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	-0.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-101%)	-0.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	-0.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	-0.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-101%)	-0.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-103%)	-0.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-103%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	-0.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-0.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	2.40x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.58x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗	FY 2010 Oct 31, 2010 10-K ↗	FY 2009 Oct 31, 2009 10-K ↗	FY 2008 Oct 31, 2008 10-K ↗	FY 2007 Oct 31, 2007 10-K ↗
Return on Invested Capital (%)	-47.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-95.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-256.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	6.0% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	20.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	32.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	31.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	231.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	166.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	64.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	9.5% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	-55.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-109.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-252.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-7939.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-268.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-330.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2646.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-775.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-78.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-769.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-57.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-485%)	-118.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-887%)	—	-25.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-266%)	-24.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	13.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	28.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+92%)	51.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+244%)	84.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+460%)	—	244.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1528%)	119.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+698%)	19.3% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+29%)	172.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1048%)	17.0% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+13%)	15.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	50.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+235%)	131.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+775%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗	FY 2010 Oct 31, 2010 10-K ↗	FY 2009 Oct 31, 2009 10-K ↗	FY 2008 Oct 31, 2008 10-K ↗	FY 2007 Oct 31, 2007 10-K ↗
Interest Coverage (x)	—	—	—	—	-91.34x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-3.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-27.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-113.53x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-1.64x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	—	—	—	—	$-6.68M	—	$-24.14K	$-955.37K	$-690.28K	$-688.23K	$-1.12M	$-2.66M	$-1.54K	$-500.00	$0.00	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗	FY 2010 Oct 31, 2010 10-K ↗	FY 2009 Oct 31, 2009 10-K ↗	FY 2008 Oct 31, 2008 10-K ↗	FY 2007 Oct 31, 2007 10-K ↗
Basic EPS, GAAP (USD)	$-2.65	$-28.96	$-34.01	$-31.15	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.29	$-16.31	$-36.32	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$3.00	$7.07	$5.44	—	$0.64	$-0.45	$-0.39	$-0.33	$-1.94	$-0.18	$-0.18	$-0.15	$-0.51	$-0.01	$-0.01	$-0.00	—	—	—
Tangible Book Value per Share (USD)	$3.00	$7.07	$5.44	—	$0.64	$-0.45	$-0.39	$-0.33	$-1.94	$-0.18	$-0.18	$-0.15	$-0.51	$-0.01	$-0.01	$-0.00	—	—	—
Basic Weighted Avg Shares (shares)	1.17M	252,960	263,137	47,658	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗	FY 2010 Oct 31, 2010 10-K ↗	FY 2009 Oct 31, 2009 10-K ↗	FY 2008 Oct 31, 2008 10-K ↗	FY 2007 Oct 31, 2007 10-K ↗
Working Capital (USD)	$5.38M	$3.48M	$2.91M	$5.95M	—	—	$-547.62K	$-8.60M	$-166.28K	$435.49K	$-604.12K	$-64.95K	$-5.61M	—	—	—	—	—	—
Total Equity (USD)	$5.38M	$3.48M	$2.91M	$5.95M	$6.58M	$-13.69M	$-11.87M	$-8.60M	$-8.40M	$-6.96M	$-5.68M	$-3.70M	$-5.61M	$-34.60K	$-28.97K	$-24.05K	$-20.45K	$-10.17K	$-9.72K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗	FY 2010 Oct 31, 2010 10-K ↗	FY 2009 Oct 31, 2009 10-K ↗	FY 2008 Oct 31, 2008 10-K ↗	FY 2007 Oct 31, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	$1.07B	$1.07B	$1.07B	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	—	$50.00	$96.00	$96.00	$700.00	$4.45K	$280.00	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.11M	$-4.11M	$-8.95M	$-1.48M	$-1.61M	$-1.82M	$-3.42M	$-4.43M	$-7.05M	$-25.88M	$-13.88M	$-4.42M	$-1.08M	$-59.60K	$-4.92K	$-3.60K	$-10.29K	$-13.34K	—
Operating Cash Flow (USD)	$-2.69M	$-4.12M	$-9.56M	$-3.57M	$-1.23M	$-426.93K	$-3.25M	$-4.10M	$-3.33M	$-7.33M	$-3.55M	$-2.76M	$-525.37K	$-55.10K	$-3.60K	$-5.68K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 19 years · 79 quarters

Bone Biologics Corp

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BBLG with peers